Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroblastoma 3Lymphoma 3Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Unspecified Childhood Solid Tumor, Protocol Specific 1Subcutaneous panniculitis-like T-cell lymphoma 1Sertoli-Leydig Cell Tumor 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Leukemia 1Immunoblastic Lymphadenopathy 1Granulosa cell tumor of the ovary 1Glioma 1Fallopian Tube Neoplasms 1Enteropathy-Associated T-Cell Lymphoma 1Carcinoma, Ovarian Epithelial 1

Interventions

sargramostim 1etoposide phosphate 1Methylprednisolone 1Melphalan 1Mass Spectrometry 1Immunologic Techniques 1Genetic Testing 1Gene Expression Profiling 1Flow Cytometry 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Carboplatin 1Busulfan 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Unspecified Childhood Solid Tumor, Protocol Specific × etoposide phosphate × Clear all
NCT00897871 2013-08-12

Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer

National Cancer Institute (NCI)

Unknown
60 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡